Following 100% transfusion independence in Chinese TDT patients, new study confirms tBE is equally safe and effective for African SCD patients and TDT patients from South/Southeast Asia. SHANGHAI, Sept. 8, 2026 /PRNewswire/ -- On September 7, 2026, Shanghai, Cell Stem Cell published...
Hence then, the article about cell stem cell tbe mediated base editing therapy achieves durable clinical remission in sickle cell disease and b thalassemia across different genetic backgrounds was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Cell Stem Cell: tBE-mediated Base Editing Therapy Achieves Durable Clinical Remission in Sickle Cell Disease and β-Thalassemia Across Different Genetic Backgrounds )
Also on site :
- Noah Wyle Says Eddie Murphy Told Him to ‘F— Off’ When He Was 9 Years Old, So ‘The Pitt’ Star Always Signs Autographs for Kids Now
- Nelly Recalls Taylor Swift Flying Him Out to Perform at Her Houston Show for $50,000: ‘I Would’ve Did It for Free’
- I’ve Covered TV for 10 Years — These Are the 11 Shows I’m Most Excited for in November 2026